Autophagy regulates the hepatic protein acetylation through modulating acetyl-CoA metabolite
Abstract
Post-translational modifications (PTMs) are essential for hepatic protein function and signaling. While autophagy regulates the hepatic proteome through degradation and transcriptional control, its role in PTMs remains unclear. Using genetic and pharmacological models, we show that autophagy deficiency causes protein accumulation with increased ubiquitination, SUMOylation, methylation, and phosphorylation, but markedly reduces global protein acetylation—the hepatic acetylome—which is enhanced by autophagy activation. This acetylation loss results from decreased hepatic acetyl-CoA levels, independent of acetyltransferase or deacetylase expression. Mechanistically, NRF2 activation suppresses key acetyl-CoA biosynthetic enzymes (Acly, Acss, Mlycd, Pdha1), limiting substrate availability. Acetyl-CoA or acetate supplementation restores the protein acetylation and alleviates liver injury and inflammation in autophagy-deficient models. Similar reductions in acetylation and acetyl-CoA enzyme expression occur in preclinical models and human chronic liver disease. These findings identify a role for autophagy in regulating the hepatic protein acetylation through metabolic control of acetyl-CoA, with potential therapeutic implications.
Related
- Very low-calorie diet reduces hepatic steatosis and remodels circulating metabolite-microRNAs networks in metabolic dysfunction-associated steatotic liver disease: A pilot study
- Hypothalamic Farnesoid X Receptor deficiency alters energy balance by modulating hepatic glucose production and adipose tissue metabolism through central insulin signaling.
- Honokiol induces an autophagy and apoptosis imbalance by modulating the p62 and Nrf2 signaling loop in canine osteosarcoma
- Nanoparticle‐Mediated TIPE1 mRNA Delivery Enhances Paclitaxel Sensitivity in Triple‐Negative Breast Cancer by Modulating RAB7A Ubiquitination‐Associated Stability and Autophagy
- Gudan Wan attenuates metabolic dysfunction-associated steatohepatitis by modulating autophagy and the Bcl-2/Caspase-3/Caspase-8 apoptotic axis
BibTeX
@article{baral2026autophagy,
title = {{Autophagy regulates the hepatic protein acetylation through modulating acetyl-CoA metabolite}},
author = {Kamal Baral and Leah Spade and Shadie Shrestha and Kapil Thapa and Ramsey Rohner and Yuanyuan Li and Ghaidaa Majari and Yuhua Xue and Gang Liu and Krzysztof Moroz and Xiao-Ming Yin and Bilon Khambu},
journal = {Communications Biology},
year = {2026},
month = oct,
doi = {10.1038/s42003-026-10955-w},
url = {https://www.nature.com/articles/s42003-026-10955-w},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Autophagy regulates the hepatic protein acetylation through modulating acetyl-CoA metabolite
AU - Kamal Baral
AU - Leah Spade
AU - Shadie Shrestha
AU - Kapil Thapa
AU - Ramsey Rohner
AU - Yuanyuan Li
AU - Ghaidaa Majari
AU - Yuhua Xue
AU - Gang Liu
AU - Krzysztof Moroz
AU - Xiao-Ming Yin
AU - Bilon Khambu
PY - 2026
DA - 2026/10/09
JO - Communications Biology
DO - 10.1038/s42003-026-10955-w
UR - https://www.nature.com/articles/s42003-026-10955-w
AB - Post-translational modifications (PTMs) are essential for hepatic protein function and signaling. While autophagy regulates the hepatic proteome through degradation and transcriptional control, its role in PTMs remains unclear. Using genetic and pharmacological models, we show that autophagy deficiency causes protein accumulation with increased ubiquitination, SUMOylation, methylation, and phosphorylation, but markedly reduces global protein acetylation—the hepatic acetylome—which is enhanced by autophagy activation. This acetylation loss results from decreased hepatic acetyl-CoA levels, independent of acetyltransferase or deacetylase expression. Mechanistically, NRF2 activation suppresses key acetyl-CoA biosynthetic enzymes (Acly, Acss, Mlycd, Pdha1), limiting substrate availability. Acetyl-CoA or acetate supplementation restores the protein acetylation and alleviates liver injury and inflammation in autophagy-deficient models. Similar reductions in acetylation and acetyl-CoA enzyme expression occur in preclinical models and human chronic liver disease. These findings identify a role for autophagy in regulating the hepatic protein acetylation through metabolic control of acetyl-CoA, with potential therapeutic implications.
SN - 2399-3642
ER -